Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

284.47
-4.7800-1.65%
Post-market: 284.470.00000.00%16:15 EDT
Volume:258.19K
Turnover:73.74M
Market Cap:5.67B
PE:29.30
High:294.00
Open:291.48
Low:283.77
Close:289.25
52wk High:326.63
52wk Low:161.82
Shares:19.94M
Float Shares:19.35M
Volume Ratio:1.30
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.71
EPS(LYR):6.13
ROE:21.96%
ROA:3.99%
PB:5.86
PE(LYR):46.41

Loading ...

Sep 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 02, 2026

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 22, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 14, 2026

Major Issues Report

Form 8-K - Current report
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 25, 2026

Major Issues Report

Form 8-K - Current report
Jun 22, 2026

Major Issues Report

Form 8-K - Current report
Jun 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2026

Major Issues Report

Form 8-K - Current report